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INTRODUCTION 
 
Deep vein thrombosis is a significant cause of morbidity and mortality in 
surgical patients and one of the important preventable causes of in-patient 
mortality. Numerous studies have quoted data regarding the incidence of DVT  in 
the Western population. There is a common presumption that VTE is not so 
frequent in the Asian population, particularly the Indian subgroup. However, recent 
Indian studies have shown that the incidence of VTE in Indian population is not as 
uncommon as thought before.  
 
Lack of proper risk factor assessment tools, inadequate documentation, 
asymptomatic presentations of DVT, misdiagnosis or attribution to other diagnosis 
and inadequate follow up in the postoperative period are a few obstacles faced in 
quantifying the actual burden of DVT and the magnitude of its complications. 
Correctly identifying the risk group for DVT prophylaxis is very important to 
reduce the incidence of VTE and related morbidity and mortality. Routine DVT 
prophylaxis may increase the risk of bleeding and other complications in general 
surgery patients, in addition to the unnecessary financial burden to 
the health care delivery system . 
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The two commonly used methods to assess the VTE risk factors in patients include 
group assessment and individual assessment. Recent publications concluded that it 
would be more appropriate to use the individual risk assessment approach . Several 
individualized VTE risk assessment models (RAMs) have been proposed and 
evaluated clinically, the most notable being those developed by Caprini, Cohen, 
Kucher, Roger and NICE guidelines . The Caprini risk assessment model was 
derived more than a decade ago, based on a combination of clinical experience and 
published data. Several modifications of the model have been validated in surgical 
patients in the western population . In addition to risk assessment, the model also 
gives appropriate recommandations for prophylaxis according to the score and the 
level of risk. This RAM has been adapted several times by different individuals 
and organizations. In Asia, this risk assessment model has been adapted and 
validated in a study done in hospitalized patients in China . However, to the best of 
our knowledge, it has not been validated in the Indian population. Hence this study 
was conducted to assess the incidence of DVT in surgical patients and to assess the 
validity and reliability of adapted Caprini scoring in risk stratification for DVT 
prophylaxis. 
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 REVIEW OF LITERATURE 
Numerous studies had been conducted in risk stratification of  DVT in surgical 
patients. A few salient studies have been reviewed here. 
 
 Data by Caprini et al concludes that The Caprini RAM effectively risk-
stratifies plastic and reconstructive surgery patients for VTE risk. Among 
patients with Caprini score 8, 11.3% have a postoperative VTE when 
chemoprophylaxis is not provided. In higher risk patients, there was no 
evidence that VTE risk is limited to the immediate postoperative period. 
 
 The results of the study published by Bahl et al. in surgical hospitalized 
patients were (relative risk >15 were) swollen legs (current), history of DVT 
and age >75. The relative risk of some of these factors, notably, swollen legs 
(current), history of DVT/PE, severe lung disease (<I month), age >75 were 
much higher than those assigned in the original Caprini RAM. 
 
 
 Pannucci et al. validated the Caprini RAM in plastic surgery patients and 
found that, compared to patients with a Caprini score of 3-4, patients with a 
Caprini score of 7-8 or more were significantly more likely to develop DVT  
p < 0.001. 
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REVIEW ON VENOUS SYSTEM AND DVT 
 
Venous thrombosis is the formation of a semi-solid coagulum within the 
venous system and may occur in the superficial system (usually described as 
superficial thrombophlebitis) or the deep system (deep venous thrombosis or 
DVT). Venous thrombosis of the deep veins of the leg may be complicated by the 
immediate risk of pulmonary embolus and sudden death. Subsequently, patients 
are at risk of developing a post-thrombotic limb  and venous ulceration. While 
DVT may occur in the upper limb, it is the leg that gives rise to the vast majority of 
the morbidity and subsequent complications of this condition. 
 
HISTORY OF DVT 
 
The earliest case of DVT was described by Sushruta in his book Sushruta 
Samhita around 600–900 BC. At some point, the increased incidence of DVT in 
women after childbirth was noticed, and in the late 1700s, a public health 
recommendation was issued to encourage women to breastfeed as a means to 
prevent this phenomenon; the DVT was called "milk leg", as it was thought to 
result from milk building up in the leg. 
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In 1856, German physician and pathologist Rudolf Virchow published what is 
referred to as Virchow's triad, the three major causes of thrombosis.The triad 
provides the theoretical framework for the current explanation of venous 
thrombosis,although it was focused on the effect of a foreign body in the venous 
system and the conditions required for clot propagation. 
Multiple pharmacological therapies for DVT were introduced in the 20th century: 
oral anticoagulants in the 1940s, subcutaneous LDUH in 1962 and subcutaneous 
LMWH in 1982. Diagnoses were commonly performed by impedance 
plethysmography in the 1970s and 1980s, but the use of Doppler ultrasound 
techniques, with their increased sensitivity and specificity, largely superseded this 
method 
 
THE ANATOMY OF THE VENOUS SYSTEM OF THE LIMBS 
 
Veins are part of a dynamic and complex system that returns low-nutrient 
deoxygenated blood to the heart. Venous blood flow is dependent on multiple 
factors such as gravity, venous valves, the cardiac and respiratory cycles, blood 
volume, and the calf muscle pump. Alterations in the intricate balance of these 
factors can result in venous pathology. 
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Structure of Veins 
Veins are thin-walled, highly distensible, and collapsible. Their structure 
specifically supports the primary functions of veins to transport blood toward the 
heart and serve as a reservoir to prevent intravascular volume overload. The 
venous intima is composed of a nonthrombogenic endothelium with an underlying 
basement membrane and an elastic lamina. The endothelium produces 
endothelium-derived relaxing factors such as nitric oxide and prostacyclin, which  
help maintain a nonthrombogenic surface through inhibition of platelet aggregation 
and promotion of platelet disaggregation. Circumferential rings of elastic tissue 
and smooth muscle located in the media of the vein allow for changes in vein 
caliber with minimal changes in venous pressure. The adventitia is most prominent 
in large veins and consists of collagen, elastic fibers, and fibroblasts. When a vein 
is maximally distended, its diameter may be several times greater than that in the 
supine Arterial blood flows through the main axial arteries of the upper and lower 
limbs before returning via the deep and superficial veins. 
 
 All of the veins of the upper and lower limbs contain valves, which ensure 
that blood flows towards the heart. The superficial venous trunks in the leg are the 
greater (long) and lesser (short or small) saphenous veins which lie above the 
muscle fascia of the limb. The cephalic and basilic veins are the superficial venous 
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trunks of the arm . Although the long saphenous vein is classically said to join the 
femoral vein at the saphenofemoral junction, a fixed point in the groin 2.5 cm 
below and lateral to the pubic tubercle, it is usually encountered somewhat higher. 
The lesser saphenous vein joins the popliteal vein at the saphenopopliteal junction 
at a variable site in the popliteal fossa but generally proximally to the knee joint 
crease. Blood passing up the superficial veins enters the deep veins at the 
saphenopopliteal and saphenofemoral junctions. 
 
In the calf and thigh there are a number of valved perforating 
(communicating) veins that join the superficial to the deep veins at inconstant sites 
and which allow blood to flow from the superficial to the deep venous system. The 
most important of these are the direct perforating veins of the medial and lateral 
calf and the communicating veins around the knee and in the mid-thigh. The deep 
veins of the lower limb include three pairs of venae commitantes, which 
accompany the three crural arteries (anterior and posterior tibial and peroneal 
arteries).  
 
These six veins intercommunicate and join in the popliteal fossa to form the 
popliteal vein, which also receives the soleal and gastrocnemius veins. 
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The popliteal vein passes up through the adductor hiatus to enter the subsartorial 
canal as the superficial femoral vein, which receives the deep (profunda) femoral 
vein (or veins) in the femoral triangle to become the common femoral vein, which 
then changes its name to the external iliac vein as it passes behind the inguinal 
ligament. The internal iliac vein joins with the external iliac vein in the pelvis to 
form the common iliac vein. The left common iliac vein passes behind the right 
common iliac artery to join the right common iliac vein on the right side of the 
abdominal aorta to form the inferior vena cava. 
9 
Anatomy of the superficial and deep veins of the lower limb 
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VENOUS PATHOPHYSIOLOGY 
 
Blood enters the lower limb through the femoral arteries before passing 
through arterioles into the capillaries, which have a pressure of about 32 mmHg at 
their arterial ends. This pressure is reduced along the course of the capillaries and 
is approximately 12 mmHg at the venular end of the capillary. The pressure 
continues to fall in the main veins and is as low as −5 mmHg at the upper end of 
the vena cava where it enters the right atrium. The venous pressure in a foot vein 
on standing is equivalent to the height of a column of blood extending from the 
heart to the foot, e.g. approximately 100 mmHg .  
 
To enable blood to be returned against gravity in the standing position, an 
auxiliary pump is required in the lower limb. This is the calf muscle pump, which 
is augmented to a lesser extent by the thigh and foot pumps. The deep veins of the 
calf are capacious and are joined by blind-ending sacks called the soleal sinusoids, 
which force blood into the popliteal and crural veins during calf muscle pump 
contraction, e.g. walking.  
The foot pump also ejects blood from the plantar veins during walking. As 
the calf muscles contract, the veins are compressed and the valves only allow 
blood to pass in the direction of the heart. The pressure within the calf 
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compartment rises to 200–300 mmHg during muscle contraction. During muscle 
relaxation the pressure falls and blood from the superficial veins enters the deep 
veins through the saphenous junctions and the perforating veins. Each time this 
occurs the pressure falls in the superficial venous compartment until a threshold is 
reached, when the venous inflow keeps pace with ejection from the deep veins. 
This is normally around 30 mmHg, a fall of approximately two-thirds of the resting 
venous pressure. The net reduction in the pressure of the superficial system is 
dependent on the presence of patent deep veins, perforating veins and superficial 
veins, which must contain competent valves.  
 
Ambulatory venous hypertension is a consequence of valve failure (reflux) 
or obstruction in the venous system and may eventually lead to 
lipodermatosclerosis and ulceration. The pathophysiology of varicose vein 
development is probably related to changes in the vein wall (dysfunctional smooth 
muscle cell proliferation, collagen deposition, decreased elastin content and 
increased matrix metalloproteinases) leading to venous dilatation and secondary 
valvular incompetence rather than to a primary valvular defect, which occurs in a 
small group of patients who have total lack of venous valves. Secondary varicose 
veins may develop in patients with post-thrombotic limbs and in patients with 
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congenital abnormalities such as the Klippel–Trenaunay syndrome or multiple 
arteriovenous fistulae. Simplistically, venous disease can be divided into  
 Superficial Venous Incompetence 
 Deep Venous Incompetence  
 Combination Of These Along With Their Clinical Presentations 
 
 
Clinical Evaluation 
 
Evaluation of the venous system begins with a detailed history and physical 
examination. Risk factors for acute and chronic venous disease are identified. They 
include increased age, history of venous thromboembolism (VTE), malignancy, 
trauma and spinal cord injury, hospitalization and immobilization, obesity, 
nephrotic syndrome, pregnancy and the recently postpartum state, oral 
contraceptive use or hormone replacement therapy, varicose veins, and 
hypercoagulable states, as well as the postoperative state. Venous pathology is 
often, but not always, associated with visible or palpable signs that can be 
identified during the physical examination. There is variation among individuals in 
the prominence of superficial veins when the person is standing .  
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The superficial veins of a lean athletic person, even when normal, will 
appear large and easily visualized, but these veins will be far less obvious in the 
obese individual. The deep veins cannot be directly assessed clinically, and 
abnormalities within them can only be inferred indirectly from changes found on 
clinical examination. 
 
Chronic venous insufficiency (CVI) may lead to characteristic changes in 
the skin and subcutaneous tissues in the affected limb. CVI results from 
incompetence of venous valves, venous obstruction, or both. Most CVI involves 
venous reflux, and severe CVI often reflects a combination of reflux and venous 
obstruction. It is important to remember that although CVI originates with 
abnormalities of the veins, the target organ of CVI is the skin, and the underlying 
physiologic and biochemical mechanisms leading to the cutaneous abnormalities 
associated with CVI are poorly understood.  
 
A typical leg affected by CVI will be edematous, with edema 
increasing over the course of the day. The leg may also be indurated and 
pigmented with eczema and dermatitis. These changes are associated with 
excessive proteinaceous capillary exudate and deposition of a pericapillary 
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fibrin cuff that may limit nutritional exchange. In addition, an increase in white 
blood cell trapping within the skin microcirculation in CVI patients may lead to 
microvascular congestion and thrombosis. Subsequently, white blood cells may 
migrate into the interstitium and release necrotizing lysosomal enzymes, 
potentially leading to tissue destruction and eventual ulceration. 
 
Fibrosis can eventually develop from impaired nutrition, chronic 
inflammation, and fat necrosis (lipodermatosclerosis). Hemosiderin deposition due 
to the extravasation of red cells and subsequent lysis in the skin contributes to the 
characteristic pigmentation of chronic venous disease . Ulceration can develop 
with longstanding venous hypertension and is associated with alterations in 
microcirculatory and cutaneous lymphatic anatomy and function. The most 
common location of venous ulceration is approximately 3 cm proximal to the 
medial malleolus . 
 
Trendelenburg’s test is a clinical test, historically important but now rarely 
used, that can help determine whether incompetent valves are present and in which 
of the three venous systems (superficial, deep, or perforator) the valves are 
abnormal. There are two components to this test. First, with the patient supine, the 
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leg is elevated 45° to empty the veins, and the GSV is occluded with the 
examiner’s hand or with a rubber tourniquet. With the GSV still occluded, the 
patient stands and the superficial veins are observed for blood filling. The 
compression on the GSV is released and the superficial veins are observed for 
filling with blood. A negative result, indicating no clinically relevant venous 
reflux, is the gradual filling of the veins from arterial inflow. A positive result is 
the sudden filling of veins with standing while the GSV remains occluded 
indicating incompetent perforator and deep veins. The GSV valves are incompetent 
if the second component of the test yields a positive result. 
 
 Interpretation of the findings of Trendelenburg’s test is subjective, and 
therefore, it has largely been supplanted by the more objective noninvasive 
vascular laboratory tests to localize sites of venous reflux. 
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The three factors described by Virchow over a century ago are 
still relevant in the development of venous thrombosis.  
 
These are: 
• changes in the vessel wall (endothelial damage); 
• stasis, which is diminished blood flow through the veins; 
• coagulability of blood (thrombophili 
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There are many predisposing causes for venous thrombosis. The most 
important factor is a hospital admission for the treatment of a medical or surgical 
condition. Injury, especially fractures of the lower limb and pelvis, pregnancy and 
the oral contraceptive pill are other well-recognised predisposing factors. 
Endothelial damage is now known to be critically important. The interaction of the 
endothelium with inflammatory cells, or previous deep vein damage, renders the 
endothelial surface hypercoagulable and less fibrinolytic. 
 
Stasis is a predisposing factor seen in many of the conditions, especially in 
the postoperative period, in patients with heart failure and in those with arterial 
ischaemia. 
A number of conditions are associated with increased coagulability of the blood 
(thrombophilia). Deficiencies of antithrombin, activated protein C and protein S 
have all been shown to predispose to venous thrombosis in young patients. 
Activated protein C deficiency is associated with inheritance of the factor V 
Leiden gene and may account for the higher incidence of venous thrombosis in 
Caucasian populations . It results in a small increase in the risk of venous 
thrombosis, although it may act in concert with some of the other predisposing 
factors. A thrombophilic cause should be sought in any patient presenting with an 
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episode of venous thrombosis who gives a family history of deep vein thrombosis 
or in whom there is no other predisposing factor. 
 
Although the development of deep vein thrombosis is probably 
multifactorial, immobility (and hence stasis) remains one of the most important 
factors. Deep vein thrombosis is recognized as a complication of long-haul flights 
and other forms of travel. 
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Risk factors for venous thromboembolism 
 Acquired 
 Advanced age 
 Hospitalization/immobilization 
 Hormone replacement therapy and oral contraceptive use 
 Pregnancy and puerperium 
 Prior venous thromboembolism 
 Malignancy 
 Major surgery 
 Obesity 
 Nephrotic syndrome 
 Trauma or spinal cord injury 
 Long-haul travel (>6 hours) 
 Varicose veins 
 Antiphospholipid antibody syndrome 
 Myeloproliferative disease 
 Polycythemia 
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Inherited 
 
 Factor V Leiden 
 Prothrombin 20210A 
 Antithrombin deficiency 
 Protein C deficiency 
 Protein S deficiency 
 Factor XI elevation 
 Dysfibrinogenemia 
 
Mixed Etiology 
 
 Homocysteinemia 
 Factor VII, VIII, IX, XI elevation 
 Hyperfibrinogenemia 
 Activated protein C resistance without factor V Leiden 
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Pathology 
 
A thrombus often develops in the soleal veins of the calf, initially as a 
platelet aggregate. Subsequently, fibrin and red cells form a mesh until the lumen 
of the vein wall occludes. The coralline thrombus then progresses as a propagated 
loose red fibrin clot containing many red cells. This likely to extend up to the next 
large venous branch and it is possible for the clot to break off and embolise to the 
lung as a pulmonary embolism. In this situation the embolus arising from the lower 
leg veins becomes detached, passes through the large veins of the limb and vena 
cava, through the right heart and lodges in the pulmonary arteries. This may totally 
occlude perfusion to all or part of one or both lungs (pulmonary embolism).  
 
Acute right heart obstruction may lead to sudden collapse and death. Lung 
infarction is rare as the lung has a dual blood supply (bronchial and pulmonary 
arteries). Moderate-sized emboli can cause pyramidal-shaped infarcts. 
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Diagnosis 
 
The most common presentation of a deep vein thrombosis is pain and 
swelling, especially in the calf – usually in one lower limb ; however, bilateral 
deep   in up to 30 per cent. When the swelling is bilateral, deep vein thromboses 
must be differentiated from other causes of systemic oedema, such as 
hypoproteinaemia, renal failure and heart failure. Some patients have no symptoms 
of thrombosis and may first present with signs of a pulmonary embolism,  
e.g.   pleuritic chest pain, 
 haemoptysis  
and shortness of breath. 
 Patients may also develop shortness of breath from chronic pulmonary 
hypertension. Sometimes the leg appears cellulitic and, very occasionally, it 
may be white or cyanosed: phlegmasia alba dolens and phlegmasia cerulia dolens . 
Patients who present with venous gangrene often have an underlying neoplasm. 
 
Clinical examination for DVT is unreliable. Physical signs may also be 
absent. Mild pitting oedema of the ankle, dilated surface veins, a stiff calf and 
tenderness over the course of the deep veins should be sought. Leg pain occurs in 
about 50 per cent of patients with DVT but is non-specific. Homans’ sign – 
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resistance (not pain) of the calf muscles to forcible dorsiflexion is not specific and 
should not be elicited. Tenderness occurs in 75 per cent of patients but is also 
found in 50 per cent of patients without objectively confirmed DVT. The pain and 
tenderness associated with DVT does not usually correlate with the size, location 
or extent of the thrombus. Clinical signs and symptoms of pulmonary embolism 
occur in about 10 per cent of patients with confirmed DVT. A low-grade pyrexia 
may be present, especially in a patient who is having repeated pulmonary emboli.  
 
Patients may have signs of cyanosis, dyspnoea, raised neck veins, a fixed 
split second heart sound and a pleural rub if they are having pulmonary emboli 
causing right heart strain, although these signs may be subtle or lacking. 
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Diagnostic algorithm for evaluation of symptomatic patients with high probability 
of deep venous thrombosis 
Vascular Lab and Radiologic Evaluation 
Duplex Ultrasound DUS is now the most commonly performed test for the 
detection of infrainguinal DVT, both above and below the knee, and has a 
sensitivity and specificity of >95% in symptomatic patients.3 DUS refers to the 
combination of real-time B-mode ultrasound with pulsed Doppler capability. 
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For VTE detection, color flow imaging is an extremely useful adjunct in the 
evaluation of possible calf vein DVT and evaluation of intra-abdominal veins. 
DUS provides the ability to noninvasively visualize venous anatomy, detect 
occluded and partially occluded venous segments, and demonstrate physiologic 
flow characteristics using a mobile self-contained device. 
 
In the supine patient, normal lower extremity venous flow is phasic , 
decreasing with inspiration in response to increased intra-abdominal pressure with 
the descent of the diaphragm and then increasing with expiration as the diaphragm 
rises and intra-abdominal pressure decreases. When the patient is upright, the 
decrease in intra-abdominal pressure with expiration cannot overcome the 
hydrostatic column of pressure existing between the right atrium and the calf. 
Muscular contractions of the calf, along with the one-way venous valves, are then 
required to promote venous return to the heart. Flow also can be increased by leg 
elevation or compression and decreased by sudden elevation of intra-abdominal 
pressure (Valsalva maneuver). 
 
In a venous DUS examination performed with the patient supine, 
spontaneous flow, variation of flow with respiration, and response of flow to 
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Valsalva maneuver are all assessed. From the common femoral through the 
popliteal vein, the primary method of detecting DVT with ultrasound is 
demonstration of the lack of compressibility of the vein with probe pressure on B-
mode imaging. 
 Normally, in transverse section, the vein walls should coapt with pressure. 
Lack of coaptation indicates thrombus. Calf vein thrombi are often best detected 
by abnormalities in color flow imaging.The examination begins at the ankle and 
continues proximally to the groin. Each vein is visualized, and the flow signal is 
assessed with distal and proximal compression.  
Lower extremity DVT can be diagnosed by any of the following DUS 
findings:  
o lack of spontaneous flow 
o inability to compress the vein ,  
o absence of color filling of the lumen by color flow DUS, 
o loss of respiratoryflow variation, and venous distention.  
o lack ofvenous compression on B-mode imaging is the primary   
diagnostic variable. 
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Duplex ultrasound scan of a normal femoral vein with phasic flow signals. 
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B-mode ultrasound of the femoral vein in cross-section. The femoral vein does 
not collapse with external compression (arrows). 
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Impedance Plethysmography:  
 
Impedance plethysmography (IPG) was the primary noninvasive method of 
diagnosing DVT before the widespread use of DUS but is infrequently used today. 
Changes in electrical resistance resulting from lower extremity blood volume 
changes are quantified. IPG is less accurate than DUS for the detection of proximal 
DVT, with 83% sensitivity in symptomatic patients. It is a poor detector of calf 
vein DVT. 
 
Iodine-125 Fibrinogen Uptake 
 Iodine-125 fibrinogen uptake (FUT) is a seldom used technique that 
involves IV administration of radioactive fibrinogen and monitoring for increased 
uptake in fibrin clots. An increase of 20% or more in one area of a limb indicates 
an area of thrombus. FUT can detect DVT in the calf, but high background 
radiation from the pelvis and the urinary tract limits its ability to detect proximal 
DVT. It also cannot be used in an extremity that has recently undergone surgery or 
has active inflammation. In a prospective study, FUT had a sensitivity of 73% and 
specificity of 71% for identification of DVT in a group of symptomatic and 
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asymptomatic patients. Currently, FUT is primarily a research tool of historic 
interest. 
 
Venography :  
 
Venography is the gold standard to which other diagnostic modalities are 
compared. A small catheter is placed in a dorsal foot vein with injection of a 
radiopaque contrast agent. Radiographs are obtained in at least two projections. A 
positive study result is failure to fill the deep system with passage of the contrast 
medium into the superficial system or demonstration of discrete filling defects. A 
normal study result virtually excludes the presence of DVT. Venography is not 
routinely used in clinical practice due to invasiveness and complication risk. It is 
still, however, frequently used in researchstudies evaluating DVT prophylaxis. 
 
 
32 
 
              
VENOGRAPHY 
 
33 
 
Prophylaxis 
 
Patients who undergo major general surgical, gynecologic, urologic, and 
neurosurgical procedures without thrombo prophylaxis have a significant incidence 
of peri operative DVT. An estimated one third of the 150,000 to 200,000 VTE-
related deaths per year in the United States occur following surgery. The goal of 
prophylaxis is to reduce the mortality and morbidity associated with VTE. The first 
manifestation of VTE may be a life-threatening , and as indicated earlier, clinical 
evaluation to detect DVT before PE is unreliable. 
 
Effective methods of VTE prophylaxis involve the use of one or more 
pharmacologic or mechanical modalities. 
Currently available pharmacologic agents include low-dose 
 UFH, 
 LMWH, 
 synthetic pentasaccharides,  
 vitamin K antagonists. 
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 Mechanical methods include 
 intermittent pneumatic compression (IPC)  
 graduated compression stockings  
 
There is insufficient evidence to consider aspirin alone as adequate DVT 
prophylaxis. Methods of prophylaxis vary with regard to efficacy, and the 2012 
ACCP Clinical Practice Guidelines stratify their uses according to the patient’s 
level of VTE risk, bleeding risk, and the values and preferences of individual 
patients.  
 
Venous Thromboembolism Prophylaxis in Nonorthopedic Surgery. 
 
 The risk for VTE associated with a surgical procedure depends on the type 
of operation, type of anesthesia, duration of surgery, and other risk factors, such as 
patient age, presence of cancer, prior VTE, obesity, presence of infection, and 
known thrombophilic disorders. VTE risk can be stratified according to the 
previously mentioned risk assessment models, the Caprini score and Rogers score. 
These risk assessment models are included in the prophylaxis guidelines for 
nonorthopedic surgery.  
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A composite score is created using assigned values for each risk factor. The 
cumulative score for each patient is then used to predict thrombosis risk and 
provide recommendations regarding VTE prophylaxis. 
 
Patients at very low risk (<0.5%; Rogers score <7; Caprini score 0) who 
undergo general or abdominopelvic procedures do not require pharmacologic or 
mechanical prophylaxis; however, early ambulation is required. 
 Patients at low risk (<1.5%; Rogers score 7–10; Caprini score 1–2) should 
receive mechanical prophylaxis. 
Patients at moderate risk (3%; Rogers score >10; Caprini score 3–4) should 
receive LMWH at recommended doses, low-dose UFH, or mechanical 
prophylaxis.  
Patients at high risk (6%; Caprini score ≥5) should receive LMWH at 
recommended doses or low-dose UFH and mechanical prophylaxis.  
 
Thromboprophylaxis should continue until discharge, except in select 
high-risk patients with malignancy in whom extended-duration prophylaxis (up to 
4–6 weeks) may be beneficial. Patients with significant risk for bleeding should 
receive mechanical prophylaxis until this risk subsides. Overall, low-dose UFH 
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and LMWH reduce the risk for symptomatic and asymptomatic VTE by 60% to 
70%. The risks for bleeding differ, depending on the dosage. Lower dosages 
of LMWH appear to be associated with less bleeding risk than low-dose UFH, but 
the latter produces less bleeding risk than higher prophylactic dosages of LMWH. 
Other advantages of LMWH include once-daily dosing protocols and a lower rate 
of heparin-associated antibody formation.  
 
Fondaparinux has been compared with the LMWH dalteparin in patients 
who undergo high-risk major abdominal surgery. It also has been compared with 
IPC alone in patients undergoing non–high-risk abdominal surgery. Fondaparinux 
demonstrated rates of VTE prevention, bleeding complications,and mortality 
similar to those of LMWH. It was more beneficial than IPC alone in reducing VTE 
but with a higher rate of bleeding. 
 
Prophylactic insertion of IVC filters has been suggested for VTE 
prophylaxis in high-risk trauma patients, bariatric surgical patients, and some 
patients with malignancy who have contraindications for LMWH therapy Fatal and 
nonfatal PE can still occur in patients with vena cava interruption. As noted earlier, 
long-term complications associated with permanent IVC filters include IVC 
thrombosis and DVT. Currently, the ACCP recommends IVC filters be placed only 
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if a proximal DVT is present and anticoagulation therapy is contraindicated. IVC 
filter insertion is not recommended for primary prophylaxis. Removable IVC 
filters may be placed in patients with a temporarily increased risk of PE. The best 
patient groups for retrievable filter placement may include young trauma patients 
with transient immobility, patients undergoing surgical procedures associated with 
a high risk of PE, and patients with hypercoagulable states who cannot receive 
anticoagulation therapy for a short period of time.  
Careful follow-up is required to assure all potentially removable filters are in 
fact removed.   
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CAPRINI SCORE 
 
• The Caprini risk assessment model was utilized to score individual patients 
based on co-morbidities and peri-operative risk factors. 
•  In this model, each independent risk factor is associated with specific points 
ranging from 1 to 5, based on the risk for DVT for each factor. 
•  A total risk factor score is calculated which corresponds to the risk of 
developing DVT.  
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Treatment 
 
Once the diagnosis of VTE has been made, antithrombotic therapy should be 
initiated promptly. If clinical suspicion for DVT is high, it may be prudent to start 
treatment while the diagnosis is objectively confirmed. The goals of DVT 
treatment are the prevention of mortality and morbidity associated with PE and 
the prevention of the postthrombotic syndrome (PTS).  
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Treatment regimens may include  
 Antithrombotic therapy 
 Temporary or permanent vena cava filter placement 
 Catheter-directed or systemic thrombolytic therapy  
 Operative thrombectomy. 
 
Antithrombotic Therapy. 
 
It is initiated with IV or subcutaneous (SC) unfractionated heparin or SC low 
molecular weight heparin. Fondaparinux, a synthetic pentasaccharide, is sometimes 
also used as an alternative. An oral vitamin K antagonist, usually sodium warfarin, 
is begun shortly after initiation of IV or SC therapy. Either SC or IV therapy is 
continued until effective oral anticoagulation with warfarin is achieved as indicated 
by an international normalized ratio (INR) ≥2 for 24 hours. 
 
A minimum of 5 days of heparin or fondaparinux therapy is recommended. 
 UFH therapy is most commonly administered with an initial IV bolus of 80 
units/kg followed by a continuous IV drip at 18 units/kg per hour. The level of 
antithrombotic therapy should be monitored every 6 hours using the activated 
partial thromboplastin time (aPTT), with the goal range of 1.5 to 2.5 times control 
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values.  Hemorrhage is the primary complication of UFH therapy. The rate of 
major hemorrhage (fatal, intracranial, retroperitoneal, or requiring transfusion of 
>2 units of packed red blood cells) is approximately 5% in hospitalized patients. 
 
For patients with UFH-related bleeding complications, cessation of UFH is 
required, and anticoagulation may be reversed with protamine sulfate.  Side effects 
of protamine sulfate include hypotension, pulmonary edema, and anaphylaxis.  
Heparin-induced thrombocytopenia (HIT) results from heparin-associated 
antiplatelet antibodies (HAAbs) directed against platelet factor 4 complexed with 
heparin.  
 
HIT may lead to disastrous venous or arterial thrombotic complications. 
Platelet counts should be monitored periodically in patients receiving continuous 
heparin therapy. HIT is diagnosed based on previous exposure to heparin, platelet 
count less than 100,000, and/or platelet count decline of 50% following exposure. 
All heparin must be stopped and alternative anticoagulation initiated immediately 
to avoid thrombotic complications. 
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Another complication of prolonged high-dose heparin therapy is osteopenia. 
Heparin-induced osteopenia results from impairment of bone formation and 
enhancement of bone resorption by heparin. 
 
Low molecular weight heparins (LMWHs)  
 
are derived from the depolymerization of porcine UFH. Like UFH, LMWHs 
bind to antithrombin via a specific pentasaccharide sequence to expose an active 
site for the neutralization of factor Xa. SC LMWH injections do not require 
laboratory monitoring for anticoagulant effect, a distinct advantage over 
continuous IV infusions of UFH. There are numerous LMWHs available, 
and the various preparations differ in their anti-Xa and anti-IIa activities.  
Several meta-analyses and demonstrate a decrease in thrombotic complications, 
bleeding, and mortality with LMWHs. LMWHs also are associated with a 
decreased rate of HAAb formation and HIT (<2%) compared with UFH 
 
FONDAPARINUX  
 
currently is a synthetic pentasaccharide that has been approved by the FDA 
for the initial treatment of DVT and PE.  
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The drug is administered SC once daily with a weight-based dosing 
protocol: 5 mg, 7.5 mg, or 10 mg for patients weighing <50 kg, 50 to 100 kg, or 
>100 kg, respectively. The half-life of fondaparinux is approximately 17 hours in 
patients with normal renal function. 
  
Direct thrombin inhibitors (DTIs) 
 include recombinant hirudin, 
 argatroban, 
 bivalirudin. 
 These antithrombotic agents bind to thrombin, inhibiting the conversion of 
fibrinogen to fibrin as well as thrombin-induced platelet activation.  
 
Vitamin K antagonists,  
 
which include warfarin and other coumarin derivatives, are the mainstay of 
long-term antithrombotic therapy in patients with VTE. Warfarin inhibits the γ-
carboxylation of vitamin K–dependent procoagulants (factors II, VII, IX, and X) 
and anticoagulants (proteins C and S), resulting in formation of less functional 
proteins. Warfarin 5 to 10 mg. usually requires several days to achieve full effect 
because normal circulating coagulation proteins must first undergo their normal 
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degradation.  A steady-state  concentration of warfarin is usually not reached for 4 
to 5 days. 
 
 Warfarin therapy is monitored by measuring the INR The therapeutic target 
INR range is usually 2.0 to 3.0.The recommended duration of warfarin 
antithrombotic therapy is stratified based on whether the DVT was provoked or 
unprovoked, whether it was the first or a recurrent episode, where the DVT is 
located, and whether malignancy or thrombophilia is present. 
 
The ACCP recommendation is that 3 months of anticoagulation are 
sufficient to prevent recurrent VTE in patients with DVT occurring around the 
time of a transient risk factor (e.g., hospitalization, orthopedic or major general 
surgery). In patients with idiopathic DVT, extended-duration antithrombotic 
therapy is associated with a relative reduction in the rate of recurrent VTE 
by 75% to >90%.  
 
Warfarin therapy rarely may be associated with the development of skin 
necrosis and limb gangrene more commonly in women (4:1). The most commonly 
affected areas are the breast, buttocks, and thighs.  
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Systemic and Catheter-Directed Thrombolysis. 
 
 Patients with extensive proximal, iliofemoral DVT may benefit from 
systemic thrombolysis or catheter-directed thrombolysis (CDT).CDT appears to be 
more effective and potentially reduces acute congestive lower extremity symptoms 
more rapidly than anticoagulation alone and decreases the development of PTS. 
Several thrombolytic agents are available,  
 Streptokinase, 
 Urokinase, 
 Alteplase (Recombinant Tissue Plasminogen Activator),  
 Reteplase,  
 Tenecteplase.  
 
All share the ability to convert plasminogen to plasmin, which leads to the 
degradation of fibrin. They differ with regard to their half-lives, their potential for 
inducing fibrinogenolysis (generalized lytic state), their potential for antigenicity, 
and their FDA-approved indications for use. It is not specific for fibrin-bound 
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plasminogen, however, and its use is limited by its significant rates of antigenicity. 
Fevers and shivering occur in 1% to 4% of patients.  
 
Urokinase is derived from human neonatal kidney cells grown in tissue 
culture. Currently, it is only approved for lysis of massive PE or PE associated 
with unstable hemodynamics. 
 
Alteplase, reteplase, and tenecteplase all are recombinant variants of tissue 
plasminogen activator. Alteplase is indicated for the treatment of acute myocardial 
infarction, acute ischemic stroke, and acute massive PE. However, it often is used 
for CDT of DVT.  
 
In an effort to minimize bleeding complications and increase efficacy, CDT 
techniques were developed for the treatment of symptomatic primarily iliofemoral 
DVT. With catheter-directed therapy, venous access may be achieved through 
percutaneous catheterization of the ipsilateral popliteal vein, retrograde 
catheterization through the contralateral femoral vein, or retrograde cannulation 
from the internal jugular vein. Multi-side-hole infusion catheters, with or without 
infusion wires, are used to deliver the lytic agent directly into the thrombus. Lytic 
agents may be administered alone or, now more commonly, in combination with 
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catheter-based methods to physically break up the clot—so-called 
pharmacomechanical thrombolysis. 
 
Inferior Vena Caval Filters.  
 
    Numerous vena caval filters have been developed. Although the designs are 
variable, they all prevent pulmonary emboli, while allowing continuation of 
venous blood flow through the IVC. Early filters were placed surgically through 
the femoral vein. Currently, less invasive techniques allow percutaneous filter 
placement through a femoral vein, internal jugular vein, or small peripheral vein 
under fluoroscopic or ultrasound guidance. 
 
Placement of an IVC filter is indicated 
o for patients who have manifestations of lower extremity VTE and 
absolute contraindications to anticoagulation,  
o those that have a bleeding complication from anticoagulation therapy 
of acute VTE, 
o those who develop recurrent DVT or PE despite adequate 
anticoagulation therapy  
o patients with severe pulmonary hypertension. 
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When possible, therapy should be continued in patients with vena cava 
filters. The duration of anticoagulation is determined by the underlying VTE and 
not by the presence of the IVC filter itself. Practically speaking, however, many 
patients who require an IVC filter for recurrent VTE are the same ones who would 
benefit most from indefinite anticoagulation. In patients who are not able to receive 
anticoagulants due to recent surgery or trauma, the clinician should continually 
reassess if anticoagulation may be started safely at a later date. 
 
Placement of permanent IVC filters has been evaluated as an adjunct to 
routine anticoagulation in patients with proximal DVT.Routine IVC filter 
placement has not been shown to prolong early or late survival in patients with 
proximal DVT but did decrease the rate of PE , however; an increased rate of 
recurrent DVT was seen in patients with IVC filters . 
 
IVC filters are associated with acute and late complications. Acute 
complications include 
 thrombosis or bleeding at the insertion site  
 misplacement of the filter.  
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Late complications include  
 thrombosis of the IVC, 
 DVT,  
 breaking, 
 migration, or 
 erosion of the filter through the IVC. 
  
The rate of fatal complications is <0.12%. In some patients, the need for an 
IVC filter may be selflimited. Such patients can be treated with so-called 
removable IVC filters. Depending on the device, removable IVC filters are 
potentially removable by percutaneous endovascular techniques for up to several 
months after their initial implantation assuming the filter is no longer required and 
does not have large amounts of trapped thrombi. All temporary IVC filters are 
approved for permanent implantation, and many so-called temporary filters end up 
as permanent devices with all the potential complications of permanent IVC filters. 
 
Operative Venous Thrombectomy. 
  
 In patients with acute iliofemoral DVT, surgical therapy is generally 
reserved for patients who worsen with anticoagulation therapy and those with 
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phlegmasia cerulea dolens and impending venous gangrene. If the patient has 
phlegmasia cerulea dolens, a fasciotomy of the calf compartments is first 
performed. In iliofemoral DVT, a longitudinal venotomy is made in the common 
femoral vein and a venous balloon embolectomy catheter is passed through the 
thrombus into the IVC and pulled back several times until no further thrombus can 
be extracted. The distal thrombus in the leg is removed by manual pressure 
beginning in the foot. This is accomplished by application of a tight rubber elastic 
wrap beginning at the foot and extending to the thigh. If the thrombus in the 
femoral vein is old and cannot be extracted, the vein may be ligated. For a 
thrombus that extends into the IVC, the IVC is exposed transperitoneally and 
controlled below the renal veins. 
 
The IVC is opened and the thrombus is removed by gentle massage. An 
intraoperative completion venogram determines if any residual thrombus or 
stenosis is present. If a residual iliac vein stenosis is present, intraoperative 
angioplasty and stenting can be performed. In most cases, an arteriovenous fistula 
is then created by anastomosing the great saphenous vein (GSV) end to side with 
the superficial femoral artery in an effort to maintain patency of the 
thrombectomized iliofemoral venous segment. 
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Heparin is administered postoperatively for several days. Warfarin 
anticoagulation is maintained for at least 6 months after thrombectomy.  
 
Complications of iliofemoral thrombectomy include  
 PE in up to 20% of patients 
 death in <1%of patients. 
Survival rates for surgical pulmonary embolectomy have improved over the past 
20 years with the addition of cardiopulmonary bypass. Emergency pulmonary 
embolectomy for acute PE is rarely indicated. Patients with preterminal massive 
PE for whom thrombolysis has failed or who have contraindications to 
thrombolytics may be candidates for this procedure. Open pulmonary artery 
embolectomy is performed through a posterolateral thoracotomy with direct 
visualization of the pulmonary arteries. Mortality rates range between 20% 
and 40%. 
 
Percutaneous catheter-based techniques for removal of a PE involve 
mechanical thrombus fragmentation or embolectomy using suction devices. 
Mechanical clot fragmentation is followed by CDT.  
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PROGNOSIS 
 
The most frequent complication of proximal DVT is post-thrombotic 
syndrome, which is caused by a reduction in the return of venous blood to the 
heart. Some symptoms of post-thrombotic syndrome are pain, edema, paresthesia, 
and in severe cases, leg ulcers. An estimated 20–50% of those with DVT will 
develop it, and 5–10% will develop the severe form. PE is the most serious 
complication of proximal DVT, and the risk of PE is higher when clots are present 
in the thigh and pelvis. Distal DVT itself is hardly if ever associated with post-
thrombotic syndrome or PE. Untreated lower extremity DVT has a 3% PE-related 
mortality rate, while deaths associated with upper extremity DVT are extremely 
rare. The presence of a remaining thrombus after a DVT frequently occurs in a 
minority of people, and it increases the risk of recurrence, though to a lesser extent 
than an elevated D-dimer. In the 10 years following a DVT, approximately a third 
of individuals will have a recurrent episode. 
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AIM & OBJECTIVES : 
 
 
 
 To determine the incidence, morbidity and mortality due to Deep Vein 
Thrombosis in surgical patients, and to assess the validity and reliability of 
Adapted Caprini scoring in risk stratification for DVT  prophylaxis. 
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METHODS AND MATERIAL 
1. DESIGN OF STUDY   :  Prospective observation Study 
 
2. PERIOD OF STUDY   :  1 year (Oct 2016 to Sep 2017)                 
 
3. COLLABORATING DEPARTMENT : None 
 
4. SELECTION OF STUDY SUBJECTS : All patients satisfying inclusion 
criteria  admitted in General Surgery Department, Government Rajaji Hospital 
for a period of 1 year 
 
5. DATA COLLECTION                     : All patients undergoing either 
elective or emergency operations under regional or general anesthesia in 
general surgery department coming under eligibility criteria will be stratified 
for risk of developing DVT using Adapted Caprini Scoring System. 
 
6. METHODS            :  Prospective Observation Study 
 
7. ETHICAL CLEARANCE          :  Applied  for approval 
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8. CONSENT         :  Individual written and Informed consent  
 
9. ANALYSIS        : Statistical Analysis 
  
10. CONFLICT OF INTEREST            :  None 
 
11. FINANCIAL SUPPORT   :  Nil From The Institution 
 
12. PARTICIPANTS         :  Patients from Casualty and OPD                                     
. 
RESEARCH PROPOSAL 
 
ELIGIBILITY CITERIA:  
 
INCLUSION CRITERIA 
1. All Patients undergoing either elective or emergency operations under 
regional or general anesthesia in the department of general surgery. 
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EXCLUSION CRITERIA 
1. Patients who were diagnosed as having DVT at the time of admission. 
2. Patients on anticoagulant treatment for any reason. 
3. Patients planned for lower limb vascular interventions. 
4. Patients in whom anticoagulation therapy was contraindicated due to any 
reason.  
5. Patients on antiplatelet drugs. 
 
METHODOLOGY 
MATERIALS AND METHODS: 
SOURCE OF DATA:   
  All patients satisfying inclusion criteria admitted in General Surgery 
Department, Government Rajaji Hospital for a period of 1 year 
 
 METHOD OF COLLECTION OF DATA:  
  All patients undergoing either elective or emergency operations under regional 
or general anesthesia in general surgery department coming under eligibility 
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criteria will be stratified for risk of developing DVT using Adapted Caprini 
Scoring System. 
DATA  ANALYSIS 
 Using statistical analysis 
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ADAPTED CAPRINI SCORING SYSTEM 
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OBSERVATION AND RESULTS  
STATISTICAL ANALYSIS  
 
In the study 302 patients were assessed for risk of developing DVT using 
Adapted Caprini Scoring System and the following results were obtained.  
 
AGE DISTRIBUTION : 
  
Majority of the patients were in the age group 41-60(42.3%) and 30% 
patients in 21-40 group. Age >60 pts were found to be only 21% of total study size. 
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No of Cases
AGE No of Cases 
<20 18 
21 - 40 92 
41 - 60 128 
>60 64 
Total 302 
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AGE GROUP VS DVT: 
  
In this study the occurrence of DVT among the age group of 41 -60 is 
3.1%, whereas the occurrence of DVT among the age group >60 is 14%. 
The lower age groups had no incidence of DVT. 
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21-40 92 0 
41-60 128 4 
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SEX DISTRIBUTION 
 
Among the 302 patients studied 184 were males and 118 were females. 
  
SEX No of Cases 
Male 184 
Female 118 
Total 302 
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SEX DISTRIBUTION VS DVT: 
 
 Incidence of male patients suffering from DVT among the total study sample 
was 2.71% and female counterpart was 6.7%. There appears to be around 3 times 
increased incidence among females when compared to males 
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SYMPTOMATIC PATIENTS 
 
Among the 302 patients studied only 13 developed symptoms suggestive of  DVT 
like swelling of limb or pain. Only 21 patients were of score >7 and remaining 
majority were of score <7. 
 
TOTAL SCORE vs SYMPTOMS 
  YES NO 
<7(281) 6 275 
>7(21) 7 14 
Total 13 289 
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DOPPLER CONFIRMED CASES : 
 
  Patients who developed symptoms of DVT(13) were subjected to Doppler 
study for  confirmation of diagnosis. All the 13 patients (4.3%) with symptoms had 
DVT.    
 
 
 
 
  Out of 21 patients with score >7, 9 (42%)were diagnosed of having DVT 
which is statistically significant (<0.001). And  4 out of 281(1.4%) patients with 
score <7 had DVT. 
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  YES NO 
<7(281) 4 277 
>7(21) 9 12 
Total 13 289 
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SCORE DISTRIBUTION: 
No. of positive patients with score 3-4 was 1(7.6%) and score 5-6 was 3 (23%) and 
score of 7-8 was 9 (69.2%). 
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SYMPTOMATOLOGY- 
SCORE VS SWELLING  
 All patients(13) with DVT had swelling of affected limb .  
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  YES NO 
<7(281) 4 277 
>7(21) 9 12 
Total 13 289 
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SCORE VS PAIN 
  Out of 13 patients only 9 patients had swelling in th leg (69%). 
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<7(281) 5 276 
>7(21) 4 17 
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MALIGNANCY VS DVT: 
 84 %(11 out of 13) of the patients who developed DVT had malignancy. 
There is a statistical significance between malignancy and occurrence of DVT in 
this study which is similar to the studies conducted previously 
  TOTAL DVT PRESENT 
Malignancy 72 11 
Others 231 2 
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SMOKING VS DVT: 
 Among 65 smokers 5 developed DVT which  corresponds to 
7.6%,whereas among the 237 non smokers 8 developed DVT which corresponds to 
3.3 %.But the incidence of smoking in DVT positive cases was around 38%. 
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TYPES OF SURGERY  VS DVT 
  
DVT 
PRESENT DVT ABSENT total 
Hernioplasty 0 59 59 
Cholecystectomy 0 20 20 
Websters procedure 0 2 2 
Eversion of sac 0 7 7 
Trendelenberg procedure 1 16 17 
Hemiglossectomy 0 1 1 
Haemorrhoidectomy 0 14 14 
Parotidectomy 0 3 3 
Varicocelectomy 0 4 4 
Abdominoperineal resection 2 2 4 
Appendicectomy 0 10 10 
Excision 0 9 9 
Vesicolithotomy 0 1 1 
SSG 0 8 8 
Mesh repair 0 26 26 
Loop colostomy 1 0 1 
Laprotomy and proceed 5 15 20 
Feeding jejunostomy 0 3 3 
TEP 0 1 1 
Stopas 0 2 2 
Lumpectomy 0 14 14 
Whipples 2 1 3 
Simple mastectomy 0 1 1 
Oesophagogastrectomy 1 0 1 
Hemithyroidectomy 0 4 4 
Flap inset  0 1 1 
Wide local excision 1 4 5 
Secondary suturing 0 2 2 
Total thyroidectomy 0 18 18 
Lumbar sympathectomy 0 1 1 
Diagnostic laproscopy 0 15 15 
Modified radical mastectomy 0 17 17 
Ilio inguinal block dissection 0 1 1 
Orchidectomy 0 3 3 
Penectomy 0 1 1 
Tongur tie release 0 1 1 
Haemicolectomy 1 0 1 
Fistulectomy 0 2 2 
Lateral anal sphinterectomy 0 2 2 
Wound exploration 0 1 1 
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 From the above chart it was evident that DVT was more common in surgery which required laparotomy 
and prolonged general anesthesia. These findings were similar to the previous studies conducted earlier. 
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DISCUSSION 
 
DVT is a relatively common complication among surgical patients, with 
many risk factors, which contribute to the disease. However, it was found that 
DVT prophylaxis was not used widely, probably due to limited awareness among 
the medical fraternity regarding identification of patients at high risk who need 
prophylaxis. The use of a risk assessment model may help improve the current 
situation.  
 
The present study intended to validate the adapted Caprini RAM, which can 
be used to stratify the risk of developing DVT in hospitalized patients based on 
their individual risk factors. In the present study it was found that a high adapted 
Caprini score and the cumulative risk level was associated with an increased risk of 
DVT. The incidence of DVT events in the low and moderate  groups was zero. 
This is contrary to previous data by Caprini et al., which described the incidence in 
low risk group to be 2%, moderate risk group to be 20%.  
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The highest group in their study was described as having an incidence of 
VTE of 80%. In the present study the incidence of VTE among the highest risk 
group was found to be 84%. 
 
In the original Caprini RAM, all patients with a score >5 were placed in the 
same group. Bahl et al. modified the Caprini RAM and added a separate “super 
high risk” group (>8) and recommended an extended duration of 
chemoprophylaxis for the same. Further splitting the highest risk category patients, 
it was observed that the difference in incidence of VTE among the patients with 
adapted Caprini score of 7-8 (69%) was statistically significant (P < 0.001), while 
among the score group of 5-6 it was statistically not significant . 
 
Of all the risk factors listed in the Adapted Caprini RAM, it was found that 
age,sex, Major surgery, malignancy , patient confined to bed (>72 h), history of 
DVT/PE were associated with increased risk of DVT. (>45 min) smoking were 
found to have marginally significant risk. All these factors are well recognized risk 
factors associated with development of VTE. However, as described in the study 
by Anderson et al. these risk factors are not of equal weight. 
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Malignancy was found to be an important risk factor in our study (92%) 
which is similar to most of the studies and further risk stratification is required 
regarding the type and stage of cancer.  In this study relation between smoking and 
DVT was not significant 
 
This observation may be due to either insufficient power of the study or 
because some of these factors may not be  significant determinants of DVT risk in 
the Indian population. 
 
For some of the established parameters like, oral contraceptives or hormone 
replacement use, pregnancy or postpartum (<1 month), history of still born, 
heparin induced thrombocytopenia ,stroke (<1 month), multiple trauma (<1 
month),major lower limb arthroplasty, acute spinal cord injury, the risk of 
developing VTE could not be evaluated as there were no patients with these 
conditions in the present study. 
 
The present study had certain limitations. Firstly, only patients who had 
symptoms of DVT were evaluated for the same. Routine screening for 
asymptomatic DVT was not done, which may have resulted in a lesser incidence 
being reported. Secondly, all the parameters of thrombophilia were not evaluated 
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on any of the patients and some established risk factors (mentioned above) were 
not reported in  any of the patients in the study group and hence no information 
could be obtained about these relevant risk factors from the study population. As a 
result of this, the patients' risk level may be underestimated. Thirdly, no orthopedic 
cases were included in the study, and hence most of the parameters, which are 
assigned a high risk scoring of 5 points, were not studied.  
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CONCLUSION 
 
 
Deep vein thrombosis  is one of the significant, yet preventable causes of in-patient 
morbidity and mortality. It is important to raise awareness among medical 
fraternity regarding detection and prevention of the same. The adapted Caprini 
RAM is an economical, practical and effective tool to stratify general surgical 
patients for perioperative DVT risk. 
 
  
     Unlike the Western population, the present study found that within the high risk 
group (score >5), the risk of developing DVT is not significant in the 5-6 score 
group, as compared to that in the group with a score of >7. Hence further 
stratification of this group to provide appropriate prophylaxis only to the patients 
with scores >7 is recommended, thereby reducing complications due to DVT 
prophylaxis. However, further multicenter and larger scale validation studies for 
the use of this adapted score in this region population are recommended 
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PROFORMA  
 
Name   :     I.P. No  : 
Age  :               Unit  : 
Sex  :               D.O.A  : 
Occupation  :               D.O.D  : 
Address : 
Phone No :               D.O. Surgery 
 
CHIEF COMPLAINTS  
 
PAST HISTORY:- 
1) History of similar complaints 
2) Treatment taken 
3) History of Drug intake  
4) History suggestive of Hypertension / Diabetes / Tuberculosis / heart disease / 
jaundice / thyroid disorder.  
 
PERSONAL HISTORY:- 
Diet : Vegetarian / Mixed 
Habits : Smoking / Alcohol / Tobacco 
Bowel habits 
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Bladder 
Sleep  
   
FAMILY HISTORY:- 
 Relevant / Not 
MENSTRUAL HISTORY:- 
 Amenorrhoea / menorrhagia 
 Regular / Not 
 Duration  
 Associated / Not with pain 
 L.M.P. 
 
GENERAL PHYSICAL EXAMINATION : - 
1. General survey  
2. Body build and nourishment 
3. Appearance  
4. Attitude : Restless / Quiet 
5. Dehydration : Mild/ Moderate / Severe / Nil 
6. Anaemia / Jaundice / Clubbing Cyanosis / Lymphadenopathy / Pedal 
oedema. 
7. Eye signs  
8. Skin Changes 
9. Pulse 
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10. Temperature 
11. Respiratory rate 
12. Blood pressure 
SYSTEMIC EXAMINATION  
 Cardiovascular system 
 Respiratory System  
 Central nervous system 
 Genito - urinary system 
 Abdomen  
 
 
INVESTIGATIONS:- 
1. Blood : Hb% 
2. TLC 
3. DLC 
4. BT 
5. CT 
6. ESR 
7. Blood group and rh type. 
8. Urine : Albumin / Sugar / Microscopy 
9. Blood : sugar / Urea / creatinine 
10. ECG 
11. USG abdomen and pelvis  
12. CECT Abdomen/pelvis 
13. Colonoscopy 
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14. HPE 
15. HIV 
16. HbsAg 
17. Others 
DIAGNOSIS 
MANAGEMENT 
SURGICAL 
Pre operative instructions 
Type of Anaesthesia 
Post - operative instructions 
Post - operative period/Post - operative complication management 
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       ADAPTED CAPRINI SCORING SYSTEM 
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MASTER CHART: 
sl.no NAME  AGE  SEX IP NO DIAGNOSIS TREATMENT SCORE DVT 
1 Thangavel 45/M M 68272 Chronic cholecystitis 
Laparoscopic 
Cholecystectomy 4   
2 Ramakannan 19/M M 69785 Rt. Gynaecomastia Webster’s procedure  2   
3 Alagarsamy 70/M M 108 Rt. Hydrocele Rt. Jabolay’s procedure  4   
4 Karuppaiah  56/M M 69920 Rt. Inguinal hernia  Rt. Hernioplasty  2   
5 Murugan 63/M M 69882 Rt. Inguinal hernia  Rt. Hernioplasty  4   
6 Mayammal 39/F F 205 Lt. Varicose veins  Lt. Trendelenberg surgery  3   
7 Bose 51/M M 7070 
Carcinoma Lt. Lateral 
aspect of Tongue 
Lt. Hemiglossection with 
LT. Supraomohyoid 
dissection 3   
8 Jothi 45/F F 69865 Chronic cholecystitis  Lap. Cholecystectomy  7   
9 Pandivel 26/M M 153 Lt. Inguinal Hernia  Lap. Lt. Hernioplasty  2   
10 Meenatchi sundaram   55/M M 1669 Lt. Inguinal Hernia   Lt. Hernioplasty  4   
11 Sonai 46/M M 1787 Rt. Hydrocele Rt. Jabouley’s procedure  2   
12 Subramaniyam 75/M M 67517 Gr. II Haemorrhoids Open Hemorrhoidectomy  7   
13 MARIAPPAN 48/M M 1773 CA PAROTID LT 
TOTAL RADICAL 
PAROTIDECTOMY LT 
WITH LT MRND 4   
14 ESWAR PRABU 13/M M 2908 VARICOCELE LT 
LAP 
VARICOCELECTOMY 2   
15 MUNIYANDI 70/M M 68266 RT INGUINAL HERNIA 
RT OPEN 
HERNIOPLASTY 5   
16 AZHAGAR 70/M M 1652 LT INGUINAL HERNIA LT HERNIOPLASTY 4   
17 Padma 38/F F 1655 Carcinoma Rectum Lap/Open APR 3   
18 Alagumuthu 43/M M 5325 Mucocele of Appendix  
Laparoscopic 
Appendicectomy 3   
19 Shamugapriya 23/F F 5449 Rt. Cervical Adenopathy Excision biopsy  3   
20 Andi 63/M M 1673 Vesical calculus Open vesicolithotomy  5   
21 Raman 60/M M 2916 Rt. Inguinal hernia  
Rt. Open inguinal 
hernioplasty  4   
22 Subramani 63/M M 1754 Rt. Inguinal hernia  
Rt. Open inguinal 
hernioplasty  5   
23 Sivanandi 58/M M 1149529 Raw area Rt. Sole of foot SSG 3   
24 Logeshwari  34/f F 5260 Paraumbilical Hernia  Open mesh repair  4   
25 Loorthumarry 50/f F 70751 
Post AR/ Transverse loop 
colostomy Transverse Loop colsotomy 6   
26 Selvaraj 50/m M 69922 
Lt. Varicose veins with 
ulcer 
Lt. Trendelenberg procedure 
+ SSG  5   
27 Thangaraj  60/m M 3026 Lt. Inguinal hernia  Lt. Hernioplasty  5   
28 Arumugam 45/m M 5302 Rt. Inguinal hernia  Rt. Hernioplasty  3   
29 Karuppasamy  47/m M 5215 Rt. Epididymal cyst Excision & biopsy  1   
30 Senthilkumar 27/m M 5142 Ulcer Rt. Foot  ssg  1   
31 Ayyalakshmi 53/F F 5935 Carcinoma stomach Laparotomy & proceed  5 YES 
32 Tamilkani 21/F F 10781 Cervical Lymphadenopathy Excision biopsy  2   
33 Muthupandi 27/M M 9042 Post Cricoid growth Feeding Jejunostomy 2   
34 Rajapandi  47/M M 10670 Rt. Inguinal hernia  Rt. Inguinal Hernioplaty  3   
35 Jeyam 57/M M 8981 Lt. Inguinal hernia  Lt. Inguinal Hernioplaty  3   
36 Raman  67/M M 670 Rt. Inguinal hernia  TEP 5   
37 Chinnakaruppan  88/M M 11828 B/L Inguinal Hernia  Stoppa’s mesh repair  7   
38 Subramanian  67/M M 10445 Anal Polyp 
Polypectmy With 
Hemorrhoidectomy 4   
39 Murugesan 38/M M 7549 Haemorrhoids Haemorrhoidectomy  1   
40 Elangovan 60/M M 1108 Ca head of pancreas Whipple’s procedure 5 YES 
41 Vasanthi 71/F F 10462 Umbilical hernia Open mesh repair 6   
42 Subramanian 67/M M 16448 
Anal polyp with grade II 
Hemorrhoids 
Polypectomy with 
Hemorroidectomy 4   
43 Pandi 67/M M 13514 Lt hydrocele LT Eversion of sac 4   
44 KARPAGAM 30/F F 2783 LT PHYLLOIDES  LT SIMPLE 4   
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RECURRENT TUMOUR MASTECTOMY 
45 KAVITHA 32/F F 31555 INCISIONAL HERNIA OPEN MESH REPAIR 4   
46 MURUGANATHAN 55/M M 31562 LT INGUINAL HERNIA LT HERNIOPLASTY 4   
47 KARTHIK 27/M M 3169 LT INGUINAL HERNIA LT HERNIOPLASTY 2   
48 PANDI 46/M M 3175 LT INGUINAL HERNIA LT HERNIOPLASTY 3   
49 SIVANANDI 61/M M 3603 RT HYDROCELE 
RT EXCISION & 
EVERSION OF SAC 3   
50 Rajamani 75/F F 33011 
Hiatus Hernia with Acute 
Intestinal obstruction Laparotomy & Proceed  7 YES 
51 Muthurakku 60 F 102278 Ca OG Junction 
Thoracolaproscopic 
Esophago Gastroectomy 5 YES 
52 Shantha 75/F F 5755 Lt. Lump Breast  Excision Biopsy  6   
53 Najima Begam 32/F F 4476 Lt. Fibroadenoma breast  Excision biopsy 3   
54 Alagamuthu Pandi  27/M M 33002 Rt. Inguinal hernia  Rt. Open Hernioplasty  2   
55 Muthualagu 18/M M 33045 
Lt. Recurrent inguinal 
hernia  Lt. Open Hernioplasty  2   
56 Kulandaisamy 62/M M 31593 Rt. Hydrocele Excision & Eversion of sac  3   
57 Nallammal 70/F F 3133 Periampullary Carcinoma  Whipple’s Procedure  7 YES 
58 Balakrishnan  45/M M 33509 
Hydatid cyst – Peritoneum 
and spleen  Laparotomy & Proceed  3   
59 Bakiyalakshmi  55/F F 33858 Carcinoma Breast Rt. Rt. MRM 4   
60 Jothilakshmi 43/F F 35709 Lump Lt. Breast  Lumpectomy  3   
61 Ayyar 34/M M 35883 B/L Inguinal Hernia  Stoppa’ Procedure  3   
62 Chellakannu  63/M M 34968 Alkali Poisoning  Feeding Jejunostomy  6   
63 Periyayya  65/M M 34216 Suprapubic Growth Wide Local excision  4   
64 Baskaran  41/M M 35718 Lt. Inguinal Hernia  Lt. Inguinal Hernioplasty  3   
65 Annakodi  55/M M 68132 Carcinoma Stomach  Laparotomy & Proceed  3   
66 Muthulakhsmi 47/F F 7145 
Solitary Nodule Thyroid Lt. 
Lobe  Lt. Hemithyroidectomy  3   
67 Manikandan  20/M M 71340 Sub Acute Appendicitis  
D-Lap & Laparoscopic 
Appendcectomy  3   
68 Regudevi 40/F F 68257 Incisional Hernia  Open Mesh repair  3   
69 Veeralakshmi  45/F F 7112 
Varicose vein Rt. Lower 
Limb 
Rt. Trendelenberg Procedure 
with stripping  4   
70 Arumugam  52/M M 4301 Lt. Inguinal Hernia  Lt. Inguinal Hernioplasty  3   
71 Madhayanai  66/M M 60055 Raw area Lt. foot  Flap Inset  4   
72 Jeyalakshmi 65/F F 66649 Malignant CBD Stricture  Whipple’s procedure  6   
73 Dhanam  40/F F 4404 Lump Lt. Breast  Lumpectomy Lt. breast  3   
74 Moorthy 52/M M 71190 Umbilical hernia Open Mesh repair  4   
75 Alagar 60/M M 68134 
Squamous cell carcinoma 
gluteal region 
Wide local excision + 
rotation flap  3   
76 Renudevi  40/F F 68257 
Incisional hernia – flap 
necrosis  Secondary suturing  2   
77 Indumathi 28/F F 1091690  SNG Thyroid Rt. Side Hemithyroidectomy Rt. Side 3   
78 Sakitha  36/F F 
1091586 Umbilical Hernia  Lap/Open Onlay mesh repair  
4   
79 Arokasamy  53/M M 1091743 Varicose vein Lt. Leg Trendelenburg’s procedure  4   
80 Mariyammal  29/F F 1093112  Lt. SNG Thyroid Lt. Hemithyroidectomy  3   
81 Arulanantham 68/M M 1090919  Incisional Hernia  Open onlay mesh repair  6   
82 Jeyanthilala 60/M M 
1090416 Supraumbilical Hernia Lap/Open Onaly mesh repair  
5   
83 Backiaraj  20/M M 
1092996 Lt. Inguinal Hernia  Lt. Hernioplaty  
2   
84 Ramu  40/F F 
1092989  Papillary carcinoma – 
thyroid  
Total thyroidcectomy with 
B/L MRND 2   
85 Nasardheen 50/M M 1094702  B/L Inguinal Hernia  B/L Hernioplasty  3   
86 Thangaraj  42/M M 1093167 TAO Rt. LL Lumber sympathectomy  3   
87 Marimuthu  48/M M 
1094631 Varicose veins Lt. LL Lt. LL Trendelenburg 
surgery  4   
88 Siva  34/F F 104489  Cholelithiasis Lap/Open Cholecystectomy 3   
89 Rajesh 27/M M 
48106 Sub acute intestinal 
obstruction 
D-Lap & Proceed  
3   
90 Panchavarnam 62/F F 1104650 ? Pseuomyxoma Peritonei D-Lap & Proceed 6   
91 Thavamani  45/F F 1104541 Lump Lt. Breast Lt. Lumpectomy  3   
92 Karupayee 63/F F 
1101498 Raw area Rt. Medial lower 
Leg 
Split skin graft Rt. Lower leg  
5   
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93 
Saraswathi 47/F F 11053577 Carcinoma Lt. breast 
Lt. Modified Radical 
Mastectomy  3   
94 
Vellaisamy 70/M M 1101869 Carcinoma Penis  
emasculation with B/L 
ilioninguinal block 
dissection 7 YES 
95 Kamala 40/F F 1103507 Umbilical Hernia  Mesh repair  3   
96 
Saraswathi 47/F F 11053577 Carcinoma Lt. breast 
Lt. Modified Radical 
Mastectomy  3   
97 
Vellaisamy 70/M M 1101869 Carcinoma Penis  
emasculation with B/L 
ilioninguinal block 
dissection 4   
98 Kamala 40/F F 1103507 Umbilical Hernia  Mesh repair  3   
99 chinnasamy 45/m M 1106125 post – hartmann status laparotomy & proceed 3   
100 muthuram 40/m M 1104538 ileocaecal tb d – lap & proceed 2   
101 varsaraja 36/m M 48322 sub acute appendicitis d – lap & proceed 2   
102 vignesh 20/m M 1107476 sub acute appendicitis d – lap & proceed 2   
103 chitra 48/f F 1107267 lt lump breast lt lumpectomy 4   
104 sentamizh selvi 39/f F 1107272 lt lump breast lt lumpectomy 2   
105 seenu 27/M M 1107377 SUB acute appendicitis lap appendicectomy 2   
106 sivamurugan  38/M M 1108568  chronic appendicitis lap appendicectomy 2   
107 sentamil selvi 39/F F 1107272 lt. lump breast lt. lumpectomy 2   
108  chitra 48/F F 1107267 lt. lump breast lt. lumpectomy 4   
109 deivendran 56/M M 1107295 rt. direct inguinal hernia rt. hernioplasty 4   
110 rengarsaj 64/M M 1105944  ca stomach laparotomy & proceed  6   
111 vasantha 50/F F 1108577 
post- gastectomy efferent 
loop obstruction laparotomy & proceed  5   
112 manikandan 31/M M 1107425 cholelithiasis 
laparoscopic 
cholecystectomy 3   
113 rajaram 71/M M 1106687 rt. direct inguinal hernia rt. hernioplasty  6   
114 Dhanalakshmi 43/F F 3058 
BILATERAL OVARIAN 
CYST WITH 
ADENOMYOSIS 
LAPAROTOMY & 
PROCEED  5   
115 Gomathi 48/F F 11108718 
CALCULUS 
CHOLECYSTITIS  
OPEN 
CHOLECYSTECTOMY 4   
116 Silambayee 70/F F 18086 
CARCINOMA BREAST 
RT. 
RT. SIDE MODIFIED 
RADICAL MASTECTOMY  5   
117 Balasubramani 55/M M 1108569 
RT. SUBMANDIBULAR 
GLAND TUMOUR EXCISION  5   
118 Thangadurai  44/M M 1108812 
VARICOSE VEIN RT. 
LEG 
RT. SIDE 
TRNDELENBURG 
PROCEDURE  4   
119 Kallarasu 25/M M 48333 
FOURNIERS 
GANGRENE SSG / CIRCUMCISION  2   
120 
rajendran 55/M M 1111603  malignant gist – stomach + 
jejuneum 
laparotomy & proceed  
6   
121 chandramohan 35/M M 1115418 urachus diverticulum d-lap & proceed  2   
122 GOPI 57 M 122321 Ca Stomach 
LAPAROTOMY & 
PROCEED 6   
123 SARAVANA  76 M 125673 
RIGHT INGUINAL 
HERNIA RIGHT HERNIOPLASTY 6   
124 NALLAL 67/M M 1115998 LIVER ABSCESS D – LAP & PROCEED 6   
125 SWAMI 56 M 654322 B/L INGUINAL HERNIA B/L HERNIOPLASTY 5   
126 BRUCE 60 M 543234 
LEFT RECCUR.  
INGUINAL HERNIA L HERNIOPLASTY 4   
127 BALASUBRAMANIAN 46/M M 1117645 
GRADE IV 
HAEMORRHOIDS HAEMORRHOIDECTOMY 3   
128 MAADATHI 65/F F 1121987 hydatid cyst – liver laparotomy & Proceed  4   
129 SARASU 38/F F 1121959 cholelithiasis lap/open  cholecystectomy  4   
130 VIJAYALAKSHMI  30/F F 1121610 cholelithiasis lap/open  cholecystectomy  2   
131 CHANDRALEKHA 17/F F 1121817 sub acute appendicitis  lap-appendicectomy  2   
132 VISAK 19/M M 1121819 lt. undescended testis d-lap & proceed  2   
133 vijayalakshmi 55 F 1120617 ca rectum 
abdomino perineal 
resection 7 YES 
134 rajeshwari 19/F F 1121437 mng thyroid completion thyroidectomy 2   
135 asokan 67/M M 1120662 cholelithiasis lap/open cholecystectomy 6   
136 ANANDA NAYAGI 25/F F 1122922 MNG THYROID 
TOTAL 
THYROIDECTOMY 7   
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137 MARIA LYDIA 22/F F 1126185 LUMP RT BREAST RT LUMPECTOMY 2   
138 SUGANTHI 19/F F 1126167 LUMP LT BREAST LT LUMPECTOMY 2   
139 MUKAYEE 45 F 1256557 VARICOSE VEIN Trendelenburg’s procedure  4   
140 MUTHULAKSHMI 16/F F 1124718 LIPOMA BACK EXCISION 1   
141 NASRATH 53/F F 1121967 LT VARICOSE VEIN  PERFORATOR LIGATION 5   
142 KUMAR 48/M M 1126243 RT INGUINAL HERNIA RT HERNIOPLASTY 3   
143 TAMILALAGU 35/M M 1124802 RT INGUINAL HERNIA RT HERNIOPLASTY 2   
144 MARIMUTHU 30/M M 1124238 
LT TESTICULAR 
INFRACTION LT ORCHIDECTOMY 2   
145 AMUTHA  45/f F 1123294 CHOLELITHIASIS 
LAP/ OPEN 
CHOLECYSTECTOMY 5   
146 PERIYADURAI 40/m M 1124765 RT. PAROTID TUMOUR 
SUPERFICIAL 
PAROTIDECTOMY 3   
147 PANCHAVARNAM 50/m M 1124740 CARCINOMA PENIS TOTAL PENECTOMY 6   
148 NATARAJAN 57/m M 11247773 
LT. SIDE VARICOSE 
VEIN 
LT. SIDE 
TRENDELENBURG 
PROCEDURE  5   
149 MUTHU 60/m M 1126117 
RT. EPIDYMOORHITIS 
WITH RT. HYDROCELE RT. ORCHIDECTOMY  5   
150 GEETHA 46/f F 11126157 
CALCULOUS 
CHOLECYSTITIS 
LAP/OPEN 
CHOLECYSTECTOMY 4   
151 LAKSHMI 65/f F 1124827 CHOLELITHIASIS 
OPEN 
CHOELCYSTECTOMY 6   
152 VASANTHA 36/f F 1127744 
RT. SIDE SNG – WITH           
LT. SIDE 
FIBROADENOMA 
RT. SIDE 
HEMITHYROIDECTOMY  
+ EXCISION LT. SIDE 
FIBROADENOMA 3   
153 Bhagavathi amma 50/F F 1135907 Carcinoma breast  
Rt. Modified radical 
mastectomy 4   
154 Raman 18/M M 58542 Sub acute appendicitis  Lap appendicectomy 2   
155 Vinayagam 54/M M 48154 Recurrent umbilical hernia  Lap/open mesh repair 4   
156 Sulthana 25/F F 58232 Paraumbilical hernia  Lap/open mesh repair 3   
157 Muthupechi 46/F F 1132633 
Recurrent ca – breast lt. 
Side Wide local excision  5   
158 Subramaniyasami 60/M M 8138 Bilateral varicose vein 
Lt. Side trendelenburg 
procedure  5   
159 appasamy 37/M M 113516 Bilateral varicose vein 
Lt. Side trendelenburg 
procedure  3   
160 Bhagavathi devi 50/F F 1135907 Carcinoma breast  
Rt. Modified radical 
mastectomy 5   
161 Iyyappan 18/M M 58542 Sub acute appendicitis  Lap appendicectomy 2   
162 Murugesan 54/M M 48154 Recurrent umbilical hernia  Lap/open mesh repair 4   
163 Jamima begum 25/F F 58232 Paraumbilical hernia  Lap/open mesh repair 2   
164 Muthulakshmi 46/F F 1132633 
Recurrent ca – breast lt. 
Side Wide local excision  3   
165 Subramani 60/M M 8138 Bilateral varicose vein 
Lt. Side trendelenburg 
procedure  5   
166 Ayyasamy 37/M M 113516 Bilateral varicose vein 
Lt. Side trendelenburg 
procedure  3   
167 Kannan 45/M M 1135253 Displaced rt. Inguinal mesh Wound exploration  3   
168 Gurusamy 69/M M 48152 Grade iii haemorrhoids Haemorrhoidectomy  5   
169 Radhakrishnan 40/M M 1134645 Raw area lt. Limb Circumcision and grafting  3   
170 karuthammal 60/f F 1139529 cholelithiasis lap/open cholecystectomy 5   
171 thannayiram 25/m M 55527 sub acute appendicitis lap/open appendicectomy  2   
172 karuppasamy 21/m M 1140532 tongue tie tongue tie release  2   
173 mahesh 48/m M 1139535 b/l inguinal hernia b/l hernioplasty  4   
174 subramani 55/m M 1139552 b/l inguinal hernia b/l hernioplasty  4   
175 manikandan 39/m M 1138385 rt. inguinal hernia rt. hernioplasty  2   
176 vairamani 32/m M 1139670 lt. inguinal hernia lt. hernioplasty 2   
177 jawahar 48/m M 59022 grade – ii haemorrhoids HAEMORRHOIDECTOMY 4   
178 ramar 65/m M 1141635 
partial GOO/ Ca stomach 
with Liver secondaires laparotomy & proceed  7 YES 
179 murugan 50/m M 1141746 
sub acute intestinal 
obstruction laparotomy & proceed  6   
180 latha 46/f F 1140523 mng thyroid total thyroidectomy  3   
181 madurai samy 57/m M 1140571 
incisional hernia with left 
inguinal hernia lap/open mesh repair  4   
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182 gurubackiyam 60/F F 68570 carcinoma lt. breast  
lt. modified radical 
mastectomy  4   
183 raman 31/m M 70062 rt. indirect inguinal hernia  rt. hernioplasty  3   
184 kaleeswari 38/F F 3142 
RIGHT SNG POST LT. 
HEMITHYROIDECTOMY 
STATUS 
COMPLETION 
THYROIDECTOMY  2   
185 neelaVathy  24/F F 5621 CHOLELITHIASIS 
LAP/OPEN  
CHOLECYSTECTOMY  3   
186 bagavathy  65/F F 8272 CHOLELITHIASIS 
LAP/OPEN  
CHOLECYSTECTOMY  5   
187 suseela 35/F F 248 CHOLELITHIASIS 
LAP/OPEN  
CHOLECYSTECTOMY  3   
188 velsamy  58/M M 7732 
? fIBROMA lT LEG + LT. 
INGUINAL HERNIA  
EXCISION + LT. 
HERNIOPLASTY  4   
189 sekar 60/M M 7741 
RT. DIRECT INGUINAL 
HERNIA  RT. HERNIOPLASTY  5   
190 janakiraman  63/M M 159 
RT. DIRECT INGUINAL 
HERNIA  RT. HERNIOPLASTY  6   
191 sivaannamml  62/F F 3161 
GRADE III  
HAEMORRHOIDS HAEMORRHOIDECTOMY  5   
192 VELLIMALAI 70/M M 7721 SCROTAL ABDOMEN REPAIR 5   
193 MANIKAVALLI 30/F F 9314 LT LUMP BREAST LT LUMPECTOMY 3   
194 CHANDRAN 41/M M 7725 
LL PERFORATOR 
INCOMPERENCE  SUBFASCIAL LIGATION 2   
195 SELVARAJ 49/M M 9179 RT INGUINAL HERNIA RT HERNIOPLASTY 4   
196 RAVI 40/M M 9229 
LT INGUINAL HERNIA + 
MULTIPLE SEBACEOUS 
CYST SCROTUM 
LT HERNIOPLASTY + 
EXCISION 3   
197 kamauthai 66/F F 9172 carcinoma hepatic flexure 
rt. hemicolectomy with  
ileo TRANSVERSE  
anastamosis  4 YES 
198 pappa 65/F F 13646 carcinoma stomach laparotomy & proceed  7   
199 nagajothi 40/F F 13707 MNG  
TOTAL 
THYROIDECTOMY 3   
200 Sabariyar 55/M M 12221 Ca Stomach Laparotomy & Proceed  6   
201 Mariayammal 52/M M 12150 
MNG + Rectrosternal 
Extension Total thyroidectomy 3   
202 Sudha 32/F F 15452 mng Total thyroidectomy 2   
203 Jothi 45/F F 16846 cA rt. Breast  rt. mrm 3   
204 Muthuraman 48/M M 17634 rt. Indirect Inguinal Hernia  rt. Hernioplasty  5   
205 Mahalingam 75/M M 16909 
lT. Epididymoorchitis Rt. 
Hydrocele 
Lt. High inguinal 
orchidectomy 6   
206 Selvakumar 57/M M 1010 Grade III Haemorrhoids Hemorrhoidectomy  3   
207 macharani 40/F F 22215 MNG  
TOTAL 
THYROIDECTOMY  4   
208 rajendran 61/M M 20789 
LT. COMPOUND 
PALMAR GANGALION EXCISON  3   
209 kanagamani 50 F 170028 
LT. FOREARM – RAW 
AREA  SSG 4   
210 ondipuli 81 M 20754 LT. VARICOSE VEINS 
LT. TRNDELENBURGE 
SURGERY 7 YES 
211 venktaeshwaran 37 M 22196 
RT. INDRECT INGUINAL 
HERNIA  RT. HERNIOPLASTY  2   
212 malaisamy 45 M 2600 sub acute appendicitis d-lap & proceed  3   
213 shanmugavel 65 M 3983 b/l inguinal hernia b/l hernioplasty  6   
214 murasoli 52 M 2565 b/l inguinal hernia b/l hernioplasty  3   
215 mani 41 M 2572 rt. hydrocele  rt. eversion of sac  2   
216 MUTHU 45 M 25094 CA PAROTID LT. 
RADICAL LT. 
PAROTIDECTOMY  WITH 
B/L MRND  5   
217 AMMAPONNU BEEVI 35 F 27988 MNG THYROID 
TOTAL 
THYROIDECTOMY  2   
218 VEERALAKSHMI 57 F 2684 CA BREAST LT. 
LT. MODIFIED RADICAL 
MASTECTOMY  5   
219 MUTHUSAMY 66 M 27953 CHOLELITHIASIS 
LAP/OPEN 
CHOLECYSTECTOMY  5   
220 MURUGESAN 48 M 2810 EPIGASTRIC HERNIA ONLAY MESH REPAIR  3   
221 ARUNACHALAM 65 M 29370 RT. INGUINAL HERNIA  RT. HERNIOPLASTY  4   
222 MUTHUKUMARESAN 21 M 4660 
SUBACUTE 
APPENDICITIS  LAP. APPENDICECTOMY 5   
223 MURUGAN 77 M 4639 
Lt.VARICOCOELE AND 
B/L DIRECT INGUINAL 
LAP/OPEN Lt 
VARICOCOELECTOMY 4   
94 
 
HERNIA WITH B/L 
HERNIOPLASTY 
224 MAHESWARI  39 F 71389 
MULTI  NODULAR 
GOITRE 
TOTAL 
THYROIDECTOMY 4   
225 SINGAMMAL 69 F 71405 
Lt.  PARAUMBILICAL 
HERNIA 
OPEN ONLAY MESH 
REPAIR  2   
226 TAMILAZHAGAN  24 M 4655 FISTULA IN  ANO FISTULECTOMY 6   
227 Jeyaraman 59 M 4654 Carcinoma Rectum Abdomino perineal resection  2   
228 Balamani  61 F 4842 Carcinoma Lt. Breast  
Lt. Modified Radical 
Mastectomy  6   
229 Arunpandi 16 M 4860 
Abdominal pain for 
evaluation  D-Lap & Proceed  6   
230 Chellapandi  21 M 5071 Lt. Varicocele Lap. Varicocelecectomy  6   
231 Pandi 50 M 4840 Epigastric hernia  Open onlay mesh repair  3   
232 Karupaiya  70 M 4648 
Rt. Direct Inguinal Hernia 
with Lt. Loin Fibroma with 
Grade II Haemorrhoids 
Rt. Hernioplasty with Lt. 
Fibroma excision with 
Haemorrhoidectomy 4   
233 Perumal 70 M 4935 Lt. Hydrocele Lt. Eversion of Sac  3   
234 Selvaraj 51 M 4649 Fistula in Ano Fistulectomy  4   
235 SELVARAJ 55 M 75522 
CALCULOUS 
CHOLECYSTITIS 
LAP/OPEN 
CHOLECYSTECTOMY  4   
236 PITCHAIYAMMAL  40 F 75582 CHOLELITHIASIS 
LAP/OPEN 
CHOLECYSTECTOMY 2   
237 VISHNUKUMAR  20 M 5812 LT. VARICOCELE 
LT. LAP/OPEN 
VARICOCELECTOMY  2   
238 SURESH 20 M 77121 
SUB ACUTE 
APPENDICITIS 
LAP/OPEN 
APPENDICECTOMY  2   
239 RAMANARAYANAN 24 M 71122 
SUB ACUTE 
APPENDICITIS 
LAP/OPEN 
APPENDICECTOMY  7   
240 SAMEERABANU 13 F 77205 
ABDOMINAL PAIN FOR 
EVALUATION/ ? 
MESENTERIC ADENITIS  D-LAP & PROCEED  2   
241 PANDIJYTHOI 40 F 5179 LUMP RT. BREAST  Rt. LUMPECTOMY  6   
242 ABUSALI 58 M 5096 EPIGASTRIC HERNIA 
OPEN ONLAY MESH 
REPAIR  7   
243 ALAGAPPAN 38 M 77117 
RT. DIRECT INGUINAL 
HERNIA  RT. HERNIOPLASTY  2   
244 Shanthi 34 F 697 Acute appendicitis D-Lap & Proceed  2   
245 Jamuna 31 F 637 Incisional Hernia  Mesh repair  3   
246 Muthumari 45 F 70352 Lt. Lump Breast Lumpectomy  4   
247 Selvi  40 F 4245 Intestinal obstruction D-lap & Proceed  5   
248 Ramesh 54 M 6037 Rt. Inguinal Hernia  Rt. Hernioplasty  4   
249 THANGASAMY 65 M 221 
ILEO ILEAL 
INTUSSUSCEPTION D-LAP & PROCEED 6   
250 
GURUNATHA 
PERUMAL 26 M 221 
RT BREAST 
GYNAECOMASTIA WEBSTER PROCEDURE 3   
251 NAGAPPAN 51 M 221 UMBILICAL HERNIA MESH REPAIR 4   
252 Annalakshmi  30 F 574 Lt. SNG Thyroid Near total thyroidectomy  2   
253 Jyothi 35 F 597 MNG Thyroid  Near total thyroidectomy 2   
254 Karpagam 50 F 577 Rt. Phylloides tumour Rt. MRM / SCM 3   
255 Podhum ponnu  35 F 575 Rt. Ca breast  Rt. MRM 3   
256 POTHUMPONNU 30 F 207 CA RT BREAST RT MRM 5   
257 RAVI 57 M 221 B/L INGUINAL HERNIA B/L HERNIOPLASTY 4   
258 SHANMUGAVEL 59 M 221 
GRADE III 
HAEMORRHOIDS HAEMORRHOIDECTOMY 5   
259 Manikandan  39 M 17072 
B/L Varicose vein with raw 
area Rt. Leg 
Rt. Trebdelenberg procedure 
with SSG  3   
260 Chinnathai 59 M 1020 Rt. Inguinal Hernia  Rt. Hernioplasty  4   
261 Ramu 45 M 17156 Rt. Inguinal Hernia  Rt. Hernioplasty  6   
262 Kaleeswran 30 M 6801 Grade IV Haemorrhoids Haemorrhoidectomy  5   
263 Suresh kumar 35 M 6616 Fissure in Ano Lateral Anal sphincterotomy  5   
264 Ramarajan 55 M 17079 Fissure in Ano Lateral Anal sphincterotomy  3   
265 Lakhsmi 77 F 17050 Ca rectum & Anal Canal  
Abdomino-Perineal 
resection  7 YES 
266 Eswari 59 F 17554 Ca Rt. Breast  
Rt. MRM with Axillary 
dissection  5   
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267 Geetha 32 F 21065 Recurrent Incisional Hernia  Mesh repair  3   
268 Saminathan  55 M 1477 Rt. Inguinal Hernia  Rt. Hernioplasty  4   
269 SHANMUGAM 59 M 25272 
 PARA-UMBILICAL 
HERNIA WITH RT. 
INGUINAL HERNIA 
MESH REPAIR WITH RT. 
HERNIOPLASTY  5   
270 VIJAYA 45 F 25279 LUMP LT. BREAST  LT. LUMPECTOMY 3   
271 KALLANAI 18 M 26974 
RT. RECURRENT 
INGUINAL HERNIA  RT. HERNIOPLASTY  2   
272 
KULANDHAI 
THERASA 45 F 1470 
POST RT. MRM WOUND 
GAPING  SECONDARY SUTURING  3   
273 DHANAPAL 28 M 25312 
VARICOSE VEINS RT. 
LOWER LIMB  
RT. TRENDELENBERG 
PROCEDURE WITH 
PERFORATOR LIGATION  3   
274 NATARAJAN  70 M 25498 
CORROSIVE ACID 
POISONING  FEEDING JEJUNOSTOMY  3   
275 MURUGAN  47 M 181655 GR. III HAEMORRHOIDS HAEMORRHOIDECTOMY 3   
276 Annalakshmi 21 F 33423 Rt. SNG Thyroid  Total Thyroidectomy  2   
277 Silambayee 65 F 30636 Ca stomach Laparotomy and Proceed  7   
278 Vanapetchi 70 F 30598 Rt. Ca breast  Rt. MRM 6 YES 
279 Palaniyandi 30 M 31200 Incisional hernia  Mesh repair  3   
280 Ganesh 58 M 216359 Rt. Inguinal Hernia  Rt. Hernioplasty  3   
281 Senthamarai 31 F 33396 Lt. Breast Fibroadenoma Excision biopsy  2   
282 Chellappa 70 M 6732 Scrotal Raw Area  SSG scrotum  7   
283 Muthualagu  50 F 36307 Carcinoma stomach Laparotomy & Proceed  6   
284 Pappathi 50 F 34776 MNG Thyroid  Total Thyroidectomy  3   
285 Deivakani 54 F 36347 Carcinoma Rt. Breast  Rt. MRM 4   
286 Thangam 68 M 37475 
Lt. Bubonocele with B/L 
Hydrocele  
Lt. Hernioplasty with B/L 
Eversion of sac  2   
287 Mayilvaganam 37 M 36343 Rt. Inguinal Hernia  Rt. Hernioplasty  2   
288 Raju 59 M 3478 Rt. Inguinal Hernia  
Rt. Hernioplasty Desarda 
Technique  3   
289 Seeniammal 65 F 3596 Raw area Rt. Foot SSG  3   
290 Ramanthan 77 M 62357 Ca stomach Laparotomy & proceed  7   
291 Meenatchi  70 F 63973 Rt. SNG Thyroid Total Thyroidectomy  6   
292 Karruppaiyah 48 M 65672 
Rt. Irreducible Inguinal 
Hernia  Rt. Hernioplasty  3   
293 JABBAR 48/m M 59022 grade – ii haemorrhoids HAEMORRHOIDECTOMY 4   
294 RASU 65/m M 1141635 
partial GOO/ Ca stomach 
with Liver secondaires laparotomy & proceed  7 YES 
295 MUSALMAN 50/m M 1141746 
sub acute intestinal 
obstruction laparotomy & proceed  6   
296 GEETHA 46/f F 1140523 mng thyroid total thyroidectomy  3   
297 madurai muthu 57/m M 1140571 
incisional hernia with left 
inguinal hernia lap/open mesh repair  4   
298 backiam 60/F F 68570 carcinoma lt. breast  
lt. modified radical 
mastectomy  4   
299 ramalingam 31/m M 70062 rt. indirect inguinal hernia  rt. hernioplasty  3   
300 kaliyamma 38/F F 3142 
RIGHT SNG POST LT. 
HEMITHYROIDECTOMY 
STATUS 
COMPLETION 
THYROIDECTOMY  2   
301 neelima 24/F F 5621 CHOLELITHIASIS 
LAP/OPEN  
CHOLECYSTECTOMY  3   
302 bangaru 65/F F 8272 CHOLELITHIASIS 
LAP/OPEN  
CHOLECYSTECTOMY  5   
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